These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 36594084

  • 1. Inhibition of androgen receptor enhanced the anticancer effects of everolimus through targeting glucose transporter 12.
    Cao B, Zhao R, Li H, Xu X, Gao J, Chen L, Wei B.
    Int J Biol Sci; 2023; 19(1):104-119. PubMed ID: 36594084
    [Abstract] [Full Text] [Related]

  • 2. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA, Tsouko E, Lin C, Rajapakshe K, Spencer JM, Wilkenfeld SR, Vakili SS, Pulliam TL, Awad D, Nikolos F, Katreddy RR, Kaipparettu BA, Sreekumar A, Zhang X, Cheung E, Coarfa C, Frigo DE.
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.
    Lev A, Lulla AR, Ross BC, Ralff MD, Makhov PB, Dicker DT, El-Deiry WS.
    Mol Cancer Res; 2018 May; 16(5):754-766. PubMed ID: 29588330
    [Abstract] [Full Text] [Related]

  • 7. The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer.
    Fard SS, Saliminejad K, Sotoudeh M, Soleimanifard N, Kouchaki S, Yazdanbod M, Mahmoodzadeh H, Ghavamzadeh A, Malekzadeh R, Chahardouli B, Alimoghaddam K, Ghaffari SH.
    Anticancer Agents Med Chem; 2019 May; 19(17):2097-2107. PubMed ID: 31566139
    [Abstract] [Full Text] [Related]

  • 8. Functional characterization and tissue localization of the facilitative glucose transporter GLUT12.
    Matsuo S, Hiasa M, Omote H.
    J Biochem; 2020 Dec 26; 168(6):611-620. PubMed ID: 32761185
    [Abstract] [Full Text] [Related]

  • 9. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
    Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, Yu BQ, Su LP, Li C, Yan C, Gu QL, Zhu ZG, Yan M, Liu B.
    Oncotarget; 2014 Nov 15; 5(21):10584-95. PubMed ID: 25301736
    [Abstract] [Full Text] [Related]

  • 10. Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer.
    Kato M, Banuelos CA, Imamura Y, Leung JK, Caley DP, Wang J, Mawji NR, Sadar MD.
    Clin Cancer Res; 2016 Jun 01; 22(11):2744-54. PubMed ID: 26712685
    [Abstract] [Full Text] [Related]

  • 11. Potential Roles of GLUT12 for Glucose Sensing and Cellular Migration in MCF-7 Human Breast Cancer Cells Under High Glucose Conditions.
    Matsui C, Takatani-Nakase T, Maeda S, Nakase I, Takahashi K.
    Anticancer Res; 2017 Dec 01; 37(12):6715-6722. PubMed ID: 29187448
    [Abstract] [Full Text] [Related]

  • 12. Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
    Rathkopf DE, Larson SM, Anand A, Morris MJ, Slovin SF, Shaffer DR, Heller G, Carver B, Rosen N, Scher HI.
    Cancer; 2015 Nov 01; 121(21):3853-61. PubMed ID: 26178426
    [Abstract] [Full Text] [Related]

  • 13. Functional characterization of the human facilitative glucose transporter 12 (GLUT12) by electrophysiological methods.
    Pujol-Giménez J, Pérez A, Reyes AM, Loo DD, Lostao MP.
    Am J Physiol Cell Physiol; 2015 Jun 15; 308(12):C1008-22. PubMed ID: 25855082
    [Abstract] [Full Text] [Related]

  • 14. Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy.
    Linden KC, DeHaan CL, Zhang Y, Glowacka S, Cox AJ, Kelly DJ, Rogers S.
    Am J Physiol Renal Physiol; 2006 Jan 15; 290(1):F205-13. PubMed ID: 16091581
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor variant 12 promotes migration and invasion by regulating MYLK in gastric cancer.
    Xia N, Cui J, Zhu M, Xing R, Lu Y.
    J Pathol; 2019 Jul 15; 248(3):304-315. PubMed ID: 30737779
    [Abstract] [Full Text] [Related]

  • 16. Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer.
    Liu B, Zhou M, Li X, Zhang X, Wang Q, Liu L, Yang M, Yang D, Guo Y, Zhang Q, Zheng H, Wang Q, Li L, Chu X, Wang W, Li H, Song F, Pan Y, Zhang W, Chen K.
    Cell Death Dis; 2021 May 04; 12(5):441. PubMed ID: 33947843
    [Abstract] [Full Text] [Related]

  • 17. MEK inhibition overcomes everolimus resistance in gastric cancer.
    Liu H, Yao Y, Zhang J, Li J.
    Cancer Chemother Pharmacol; 2020 Jun 04; 85(6):1079-1087. PubMed ID: 32444897
    [Abstract] [Full Text] [Related]

  • 18. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
    Wang Y, Mikhailova M, Bose S, Pan CX, deVere White RW, Ghosh PM.
    Oncogene; 2008 Nov 27; 27(56):7106-17. PubMed ID: 18776922
    [Abstract] [Full Text] [Related]

  • 19. The glucose transporter GLUT12, a new actor in obesity and cancer.
    Burgos M, Gil-Iturbe E, Idoate-Bayón A, Castilla-Madrigal R, Moreno-Aliaga MJ, Lostao MP.
    J Physiol Biochem; 2024 May 10. PubMed ID: 38727993
    [Abstract] [Full Text] [Related]

  • 20. Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.
    Justin S, Rutz J, Maxeiner S, Chun FK, Juengel E, Blaheta RA.
    Int J Mol Sci; 2020 Jun 04; 21(11):. PubMed ID: 32512849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.